Eli Lilly and Company (VIE:LLYC)
Austria · Delayed Price · Currency is EUR 917.30
+43.40 (4.97%)
Last updated: Feb 4, 2026, 1:35 PM CET
Eli Lilly and Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 65,179 | 45,043 | 34,124 | 28,541 | 28,318 | |
Revenue Growth (YoY) | 44.70% | 32.00% | 19.56% | 0.79% | 15.40% |
Cost of Revenue | 11,052 | 8,418 | 7,082 | 6,630 | 6,973 |
Gross Profit | 54,127 | 36,624 | 27,042 | 21,912 | 21,345 |
Selling, General & Admin | 11,094 | 8,132 | 6,941 | 6,068 | 6,142 |
Research & Development | 13,337 | 10,991 | 9,313 | 7,191 | 6,931 |
Operating Expenses | 24,431 | 19,123 | 16,255 | 13,258 | 13,073 |
Operating Income | 29,696 | 17,502 | 10,787 | 8,653 | 8,273 |
Interest Expense | -642 | -780.6 | -485.9 | -331.6 | -339.8 |
Interest & Investment Income | - | 175.2 | 173.6 | 62.8 | 25.4 |
Currency Exchange Gain (Loss) | - | -288.3 | -26.4 | -191.3 | -204.6 |
Other Non Operating Income (Expenses) | 71 | 262.9 | -6.3 | 177 | 256 |
EBT Excluding Unusual Items | 29,125 | 16,871 | 10,442 | 8,370 | 8,010 |
Merger & Restructuring Charges | - | - | - | - | -13 |
Gain (Loss) on Sale of Investments | - | -49.5 | -20.2 | -410.7 | 176.9 |
Asset Writedown | -484 | - | - | - | - |
Legal Settlements | - | -435 | - | - | - |
Other Unusual Items | - | -425.6 | -67.7 | -244.6 | -1,048 |
Pretax Income | 25,731 | 12,680 | 6,555 | 6,806 | 6,156 |
Income Tax Expense | 5,091 | 2,090 | 1,314 | 561.6 | 573.8 |
Earnings From Continuing Operations | 20,640 | 10,590 | 5,240 | 6,245 | 5,582 |
Net Income | 20,640 | 10,590 | 5,240 | 6,245 | 5,582 |
Net Income to Common | 20,640 | 10,590 | 5,240 | 6,245 | 5,582 |
Net Income Growth | 94.90% | 102.08% | -16.08% | 11.88% | -9.88% |
Shares Outstanding (Basic) | 899 | 901 | 900 | 902 | 907 |
Shares Outstanding (Diluted) | 899 | 904 | 903 | 905 | 912 |
Shares Change (YoY) | -0.53% | 0.09% | -0.15% | -0.78% | -0.09% |
EPS (Basic) | 22.95 | 11.76 | 5.82 | 6.93 | 6.15 |
EPS (Diluted) | 22.95 | 11.71 | 5.80 | 6.90 | 6.12 |
EPS Growth | 95.99% | 101.90% | -15.94% | 12.75% | -9.87% |
Free Cash Flow | - | 3,760 | 792.5 | 5,731 | 6,056 |
Free Cash Flow Per Share | - | 4.16 | 0.88 | 6.34 | 6.64 |
Dividend Per Share | 6.000 | 5.200 | 4.520 | 3.920 | 3.400 |
Dividend Growth | 15.38% | 15.04% | 15.31% | 15.29% | 14.87% |
Gross Margin | 83.04% | 81.31% | 79.25% | 76.77% | 75.38% |
Operating Margin | 45.56% | 38.86% | 31.61% | 30.32% | 29.21% |
Profit Margin | 31.67% | 23.51% | 15.36% | 21.88% | 19.71% |
Free Cash Flow Margin | - | 8.35% | 2.32% | 20.08% | 21.39% |
EBITDA | 31,578 | 19,268 | 12,315 | 10,176 | 9,820 |
EBITDA Margin | 48.45% | 42.78% | 36.09% | 35.65% | 34.68% |
D&A For EBITDA | 1,882 | 1,767 | 1,527 | 1,523 | 1,548 |
EBIT | 29,696 | 17,502 | 10,787 | 8,653 | 8,273 |
EBIT Margin | 45.56% | 38.86% | 31.61% | 30.32% | 29.21% |
Effective Tax Rate | 19.79% | 16.48% | 20.05% | 8.25% | 9.32% |
Advertising Expenses | - | 1,440 | 1,120 | 966.8 | 1,240 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.